Zimmer Biomet Holdings, Inc. Overview
Pro stress-test →Zimmer Biomet is a global medical technology company that designs, manufactures, and markets orthopedic reconstructive products including knee and hip products, sports medicine, biologics, foot and ankle, craniomaxillofacial and thoracic products. The company has demonstrated strong demand for its hip and knee implant portfolios.
Strategic Profile
Pro stress-test →Zimmer Biomet is transitioning to a fully dedicated U.S. sales force, expecting short-term disruption but betting on long-term productivity and durable growth gains post-2027. In 2025, the company delivered $8.23 billion in revenue and announced a $1.5 billion share repurchase program.
Competitive Landscape
Pro stress-test →Zimmer Biomet competes in the global orthopedic medical device market against major players including Stryker, Johnson & Johnson's DePuy Synthes, and Smith & Nephew. The company maintains competitive advantages through its diversified product portfolio spanning joint reconstruction, sports medicine, trauma, and craniomaxillofacial products, along with recent strategic acquisitions and a strong balance sheet.
Industry Context
Zimmer Biomet Holdings, Inc. operates in Medical Devices - Orthopedic Reconstructive Products.
Key facts
Headquarters: Warsaw, Indiana · Revenue: $8.2B · Market cap: $18.6B